newsfilter
← Latest News
GlobeNewswire·

Immunomedics Announces Commercial Availability of TRODELVY™ in the United States

MORRIS PLAINS, N.J., May 04, 2020 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug...